PGC ASX · Health Care

Paragon Care Ltd

Announcements, last 12 months: 50
Price sensitive, last 12 months: 13
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
20 Oct 2026, 3:57 PM	Notification of cessation of securities - PGC
16 Oct 2026, 8:22 AM	2026 Notice of Annual General Meeting
16 Oct 2026, 8:22 AM	Appointment of Chief Financial Officer
2 Oct 2026, 1:59 PM	Change of Auditor
23 Sep 2026, 9:13 AM	FY26 Corporate Governance Statement
23 Sep 2026, 9:12 AM	FY26 Appendix 4G
23 Sep 2026, 9:12 AM	FY26 Audited Financial Results Release Price sensitive	AI summary
23 Sep 2026, 9:10 AM	FY26 Annual Report
16 Sep 2026, 8:30 AM	Notification of buy-back - PGC
16 Sep 2026, 8:27 AM	On-Market Share Buy-Back Announcement Price sensitive	AI summary

Sign in to see all PGC announcements.

Guidance history

1 Jun 2026	Forecasted FY26 revenue: A$3.7b, Underlying EBITDA: A$95m to A$100m
25 Feb 2026	ParagonCare confirms its previously announced full-year FY26 guidance, targeting revenue of $3.6-$3.7 billion and underlying EBITDA of $97-$107 million.
25 Feb 2026	FY26 full-year guidance: revenue $3.6 - $3.7 billion, underlying EBITDA $97 - $107 million, net debt / underlying EBITDA (proforma) c. 2.0x (before any further acquisitions). Infinity Group debt of $48.5 million (inc. GST) fully provided 31 December 2025.

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow PGC to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.